Trademark Overview
On Thursday, August 14, 2025, a trademark application was filed for GENINVO with the United States Patent and Trademark Office. The USPTO has given the GENINVO trademark a serial number of 99338269. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, August 14, 2025. This trademark is owned by GenInvo, Inc.. The GENINVO trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Business consulting for pharmaceutical and life sciences companies in the fields of clinical research, clinical trials, and applications for drug approval; data analytics and data management services in the pharmaceutical and life sciences fields of clinical research; business consulting and management in the field of clinical trials, namely, clinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; providing independent review of clinical trial data for clinical trial purposes
Providing temporary use of online non-downloadable software and applications for clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; providing temporary use of online non-downloadable software and applications using artificial intelligence (AI) for clinical trial data ingestion, data anonymization, data collaboration, data transformation, predictive data analysis, document review, metadata management, patient data anonymization, and automated reporting; custom design of computer application software; cloud managed services in the nature of remote infrastructure management services for migration, configuration, monitoring, and management of cloud computing IT systems and cloud databases; providing quality control services in the fields of clinical research, clinical trials, and applications for drug approval